Savvy Updates 9/5/23: InsuletGets TRO Against EOFlow, Beta Bionics Raises $100M, Research Grant for Liver Targeted Insulin, History/Future or DIY “Bionic Pancreas”, 1st Ten Drugs for Medicare Price Negoation, WellDoc’s Blue Star Gets FDA Clearance, Men & Women Differ in Cardiac Arrest Symptoms, CGM Companies Go Mainstream

Savvy Updates 9/5/23: InsuletGets TRO Against EOFlow, Beta Bionics Raises $100M, Research Grant for Liver Targeted Insulin, History/Future or DIY “Bionic Pancreas”, 1st Ten Drugs for Medicare Price Negoation, WellDoc’s Blue Star Gets FDA Clearance, Men & Women Differ in Cardiac Arrest Symptoms, CGM Companies Go Mainstream

Sep 5, 2023 | Diabetes Business, Featured, LOOPing, Research News, Technology Updates

Insulet gains amid winning TRO in dispute with EOFlow, CEO insider buy by Joshua Fineman for SeekingAlpha.com, 30 August 2023.   Insulet rose 8.1% at least partly after the insulin pump maker was granted a temporary restraining order in a trade secrets case...
Skip to content